Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
847.00    -2.50 (-0.29%)
Bid:
846.50
Ask:
850.00
Spread: 3.50 (0.413%)
Market Cap: £975.52m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Update

5 Sep 2018 07:00

RNS Number : 7658Z
Kainos Group plc
05 September 2018
 

5 September 2018

 

 Kainos Group plc

 

("Kainos" or "the Group")

 

Trading Update

 

Kainos Group plc, a leading provider of Digital Services and Platforms, today issues a trading update for the period from 1 April 2018 to date.

 

The Group has had a strong start to the year with the momentum seen in the second half of last year continuing into the current year. As a consequence, the Group expects the results for the year ending 31 March 2019 to be ahead of current market expectations.

 

Growth in Digital Services has been very strong, driven by both Digital Transformation and Workday. In Digital Transformation, the Group continues to deliver a number of significant ongoing engagements both for commercial clients and, as part of the UK government's digital transformation programme. In Workday Implementation, the Group is benefiting from growth in Post Deployment Services and an increasing book of business in continental Europe following geographic expansion.

 

In Digital Platforms, Kainos Smart continued its strong growth trajectory although this performance was partially offset by Evolve where market conditions remain challenging due to lack of available funding at NHS Trusts.

 

Kainos' results for the six months ended 30 September 2018 will be announced on Monday 26 November 2018.

 

For further information, please contact:

 

 

 

Kainos

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Peter McKeown, Deputy Chief Financial Officer

via FTI Consulting LLP

 

 

Investec Bank plc

Patrick Robb / Sebastian Lawrence

+44 20 7597 5970

 

 

Canaccord Genuity

Simon Bridges / Emma Gabriel

 

+44 20 7523 4606

FTI Consulting LLP

Matt Dixon / Harry Staight

+44 20 3727 1000

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

 

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

 

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers.

 

Kainos has over 1,300 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

 

Kainos is listed on the London Stock Exchange (LSE: KNOS). LEI number: 213800H2PQMIF3OVZY47

 

For further information, please visit www.kainos.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLIMFTMBJMBAP
Date   Source Headline
18th Nov 20213:34 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSKainos Half-year Report
1st Nov 20215:15 pmRNSTotal Voting Rights
1st Oct 202110:28 amRNSTotal Voting Rights
29th Sep 20213:33 pmRNSHolding(s) in Company
29th Sep 20211:18 pmRNSDirector/PDMR Shareholding
23rd Sep 20215:33 pmRNSAGM Results
23rd Sep 20215:30 pmRNSDirectorate Change
8th Sep 20213:15 pmRNSDirector/PDMR Shareholding
2nd Sep 202110:20 amRNSDirector/PDMR Shareholding
1st Sep 20215:38 pmRNSTotal Voting Rights
1st Sep 20217:00 amRNSAcquisition
1st Sep 20217:00 amRNSTrading Statement
25th Aug 20212:28 pmRNSDirector/PDMR Shareholding
18th Aug 202111:28 amRNSNotice of AGM
12th Aug 20212:05 pmRNSDirector/PDMR Shareholding
10th Aug 202112:41 pmRNSChange of Auditor
2nd Aug 202111:57 amRNSTotal Voting Rights
30th Jul 202112:25 pmRNSAnnual Financial Report
9th Jul 20216:31 pmRNSDirector/PDMR Shareholding
1st Jul 20214:35 pmRNSTotal Voting Rights
29th Jun 20213:58 pmRNSDirector/PDMR Shareholding
1st Jun 20217:00 amRNSAcquisition
24th May 20217:00 amRNSKainos Final Results
21st May 20217:00 amRNSBoard Changes
4th May 202111:49 amRNSTotal Voting Rights
16th Apr 20217:00 amRNSKainos Trading Statement
8th Apr 20213:51 pmRNSHolding(s) in Company
7th Apr 20214:02 pmRNSHolding(s) in Company
1st Apr 20214:23 pmRNSTotal Voting Rights
31st Mar 20214:14 pmRNSHolding(s) in Company
29th Mar 20214:16 pmRNSHolding(s) in Company
23rd Mar 20214:42 pmRNSHolding(s) in Company
11th Mar 20213:50 pmRNSHolding(s) in Company
1st Mar 202111:14 amRNSTotal Voting Rights
18th Feb 20214:26 pmRNSHolding(s) in Company
11th Feb 20213:28 pmRNSHolding(s) in Company
11th Feb 20212:12 pmRNSDirector/PDMR Shareholding
10th Feb 20215:00 pmRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSKainos Trading Update
31st Dec 202010:00 amRNSTotal Voting Rights
21st Dec 20207:00 amRNSKainos Appoint Independent Non-Executive Director
17th Dec 20204:05 pmRNSHolding(s) in Company
16th Dec 20206:06 pmRNSHolding(s) in Company
3rd Dec 20204:49 pmRNSDirector/PDMR Shareholding
1st Dec 20208:16 amRNSTotal Voting Rights
16th Nov 20207:00 amRNSKainos Group plc Interim results
14th Oct 20207:00 amRNSTrading Statement
24th Sep 202010:43 amRNSResult of AGM
3rd Sep 20207:00 amRNSKainos Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.